HealthTronics, Inc. (NASDAQ:HTRN) today announced that
its 4th quarter net income will fall below its previous guidance.
Un-audited preliminary results for the 4th quarter ended December 31,
2005 indicate estimated earnings will be between $0.07 and $0.10 per
fully diluted share, below previous guidance of $0.12 to $0.13 per
fully diluted share.
John Q. Barnidge, President and CEO (Interim), said, "The primary reason for the decrease is that our medical device sales fell short of estimates in the 4th quarter 2005. Our largest two business segments, Urology Services and Specialty Vehicles, performed well during the quarter. Earnings per share, on a comparable pro forma combined basis, were $0.10 in the 4th quarter 2004. Earnings per share for the year ended December 31, 2005 are estimated to be $0.40 to $0.44, as compared to the prior years' pro forma combined $0.41. We will provide a detailed review and analysis of the 4th quarter during our earnings call scheduled for March 9, 2006."
4th Quarter Earnings Call
The Company will issue its financial results for the fourth quarter ended December 31, 2005 on Wednesday, March 8, 2006 after the stock market closes. Accordingly, John Q. Barnidge, President and CEO (interim), will conduct an accompanying conference call on Thursday, March 9, 2006 at 10.30am ET.
Interested parties may participate in the call by dialing 888-743-0342 (for international callers dial 706-679-0861) and asking for the "HealthTronics" call (conference I.D. 5245584). Please call in 10 minutes before the call is scheduled to begin. The conference call will also be webcast live via the Investors section of the Company's web site at www.healthtronics.com. To listen to the live webcast, go to the web site at least 10 minutes early to register, download and install any necessary audio software. If you are unable to listen live, the conference call will be archived on the Company's web site.
About HealthTronics, Inc.
HealthTronics provides healthcare services primarily to the Urology community and manufactures and distributes medical devices. The Company also manufactures specialty vehicles used for the transport of high-technology medical devices and broadcast & communications equipment. For more information, visit www.healthtronics.com.
Statements by the Company's management during the conference call announced in this press release that are not strictly historical, including statements regarding plans, objective and future financial performance, are "forward-looking" statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Although HealthTronics believes that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that the expectations will prove to be correct. Factors that could cause actual results to differ materially from HealthTronics' expectations include, among others, the existence of demand for and acceptance of HealthTronics' services, regulatory approvals, economic conditions, the impact of competition and pricing, financing efforts and other factors described from time to time in HealthTronics' periodic filings with the Securities and Exchange Commission.
HEALTHTRONICS USE OF NON-GAAP FINANCIAL MEASURES
This press release includes financial measures for pro forma combined net income and related earnings per share amounts for the 2004 4th quarter and for the year ended December 31, 2004 for HealthTronics Surgical Services, Inc. and Prime Medical Services, Inc. "as if" the two companies had been combined during these periods. Therefore, they are not calculated in accordance with U.S. generally accepted accounting principles (GAAP). These non-GAAP financial measures may be different from non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. These non-GAAP financial measures facilitate management's internal comparisons to the Company's historical operating results, to competitors' operating results, and to estimates made by securities analysts. Management uses these non-GAAP financial measures internally to evaluate its performance. The Company believes these non-GAAP financial measures are useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, the Company has historically reported similar non-GAAP financial measures to its investors and believes that the inclusion of comparative numbers provides consistency in its financial reporting.
John Q. Barnidge, President and CEO (Interim), said, "The primary reason for the decrease is that our medical device sales fell short of estimates in the 4th quarter 2005. Our largest two business segments, Urology Services and Specialty Vehicles, performed well during the quarter. Earnings per share, on a comparable pro forma combined basis, were $0.10 in the 4th quarter 2004. Earnings per share for the year ended December 31, 2005 are estimated to be $0.40 to $0.44, as compared to the prior years' pro forma combined $0.41. We will provide a detailed review and analysis of the 4th quarter during our earnings call scheduled for March 9, 2006."
4th Quarter Earnings Call
The Company will issue its financial results for the fourth quarter ended December 31, 2005 on Wednesday, March 8, 2006 after the stock market closes. Accordingly, John Q. Barnidge, President and CEO (interim), will conduct an accompanying conference call on Thursday, March 9, 2006 at 10.30am ET.
Interested parties may participate in the call by dialing 888-743-0342 (for international callers dial 706-679-0861) and asking for the "HealthTronics" call (conference I.D. 5245584). Please call in 10 minutes before the call is scheduled to begin. The conference call will also be webcast live via the Investors section of the Company's web site at www.healthtronics.com. To listen to the live webcast, go to the web site at least 10 minutes early to register, download and install any necessary audio software. If you are unable to listen live, the conference call will be archived on the Company's web site.
About HealthTronics, Inc.
HealthTronics provides healthcare services primarily to the Urology community and manufactures and distributes medical devices. The Company also manufactures specialty vehicles used for the transport of high-technology medical devices and broadcast & communications equipment. For more information, visit www.healthtronics.com.
Statements by the Company's management during the conference call announced in this press release that are not strictly historical, including statements regarding plans, objective and future financial performance, are "forward-looking" statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Although HealthTronics believes that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that the expectations will prove to be correct. Factors that could cause actual results to differ materially from HealthTronics' expectations include, among others, the existence of demand for and acceptance of HealthTronics' services, regulatory approvals, economic conditions, the impact of competition and pricing, financing efforts and other factors described from time to time in HealthTronics' periodic filings with the Securities and Exchange Commission.
HEALTHTRONICS USE OF NON-GAAP FINANCIAL MEASURES
This press release includes financial measures for pro forma combined net income and related earnings per share amounts for the 2004 4th quarter and for the year ended December 31, 2004 for HealthTronics Surgical Services, Inc. and Prime Medical Services, Inc. "as if" the two companies had been combined during these periods. Therefore, they are not calculated in accordance with U.S. generally accepted accounting principles (GAAP). These non-GAAP financial measures may be different from non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. These non-GAAP financial measures facilitate management's internal comparisons to the Company's historical operating results, to competitors' operating results, and to estimates made by securities analysts. Management uses these non-GAAP financial measures internally to evaluate its performance. The Company believes these non-GAAP financial measures are useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, the Company has historically reported similar non-GAAP financial measures to its investors and believes that the inclusion of comparative numbers provides consistency in its financial reporting.